Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID)

2024 . Agafina, Alina | Aguiar, Valeria Cristina | Rossovskaya, Maria | Fartoukh, Muriel Sarah | Hajjar, Ludhmila Abrahao | Thiéry, Guillaume | Timsit, Jean-François | Gordeev, Ivan | Protsenko, Denis | Carbone, Javier | Pellegrini, Rita | Stadnik, Claudio Marcel Berdun | Avdeev, Sergey | Ferrer, Miquel | Heinz, Corina C | Häder, Thomas | Langohr, Patrick | Bobenhausen, Iris | Schüttrumpf, Jörg | Staus, Alexander | Ruehle, Markus | Weissmüller, Sabrina | Wartenburg-Demand, Andrea | Torres, Antoni